SCHEMBL5014732

SCHEMBL5014732

COCCNc1ncnc2c1sc1nc(N(C)Cc3cccnc3)c3c(c12)CC(C)(C)OC3

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE4B Q07343 9/20 0.59
PDE4A P27815 7/20 0.59
PDE4D Q08499 7/20 0.59
KDM4E B2RXH2 7/20 0.57
ADRB2 P07550 6/20 0.57
MAPT P10636 2/20 0.57
POLB P06746 1/20 0.52
RAD52 P43351 2/20 0.52
KMT2A Q03164 2/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
ALDH1A1 P00352 5/20 0.51
PKM P14618 1/20 0.49
HTT P42858 3/20 0.49
LMNA P02545 1/20 0.49
THRB P10828 1/20 0.49
HIF1A Q16665 1/20 0.49
NSD2 O96028 1/20 0.48
RECQL P46063 1/20 0.48
HPGD P15428 3/20 0.48
RXFP1 Q9HBX9 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5012452 0.80 PDE4B (0.76) PDE4BPDE4APDE4DKDM4EADRB2
SCHEMBL5011677 0.79 PDE4B (0.75) PDE4BPDE4APDE4DKDM4EADRB2
SCHEMBL5013042 0.79 PDE4B (0.81) PDE4BPDE4APDE4DKDM4EADRB2
SCHEMBL5011384 0.77 POLB (0.83) PDE4BPDE4APDE4DKDM4EADRB2
SCHEMBL5011499 0.76 PDE4B (0.71) PDE4BPDE4APDE4DKDM4EADRB2
SCHEMBL4051313 0.76 PDE4B (0.68) PDE4BPDE4APDE4DKDM4EPOLB
SCHEMBL5011388 0.76 KDM4E (0.73) PDE4BPDE4APDE4DKDM4EADRB2
SCHEMBL5014736 0.75 PDE4B (0.69) PDE4BPDE4APDE4DKDM4EADRB2
SCHEMBL5054674 0.75 POLB (0.54) PDE4BPDE4APDE4DKDM4EADRB2
SCHEMBL5011372 0.75 PDE4B (0.89) PDE4BPDE4APDE4DKDM4EADRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080207645-A1 Pyridothienopyrimidine Derivatives PAGES SANTACANA LUIS MIGUEL 2008-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080207645-A1 Pyridothienopyrimidine Derivatives PDE4A, PDE5A, PDE3B PDE4B 5/4885PDE4A 1/4885PDE4D 12/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.